Study of the Effect of Intestinal Microbes on Obesity: A Bibliometric Analysis

3.5.1 Co-occurrence analysis

Keywords could accurately reflect the main research point of an article, which has a high condensation in a research field and can directly point to the center of the text. Therefore, a high frequency of keywords represents hot issues in a research field and research hotspots. The keyword co-occurrence graph for the effects of intestinal microbes on obesity is shown in Figure 5. The density value was 0.0457. The ten most frequent keywords were gut microbiota, obesity, inflammation, insulin resistance, intestinal microbiota, health, metabolism, diet, gut microbiome, and metabolic syndrome (Table 7).

• Download figure
• Open in new tab

FIGURE 5

Keyword co-occurrence network for the effect of intestinal microbes on obesity research (node label: by centrality, label font size: uniformed).

3.5.2 Cluster analysis

The clustering analysis of the keywords yielded 288 nodes and 1083 links, with a Q value of 0.4123 (>0.3) and an S value of 0.7178 (>0.5), which are two important indicators to evaluate the significance of the clustering effect. There were 8 clusters, including diversity, insulin resistance, short-chain fatty acids, activation, food intake, bariatric surgery, body composition, and nonalcoholic fatty liver disease (Figure 6). “diversity” # 0 was the largest cluster, followed by “insulin resistance” # 1 and “short-chain fatty acids” # 2. Timeline View analysis was conducted to further analyze the keywords of the effects of intestinal microbes on obesity (Supplementary Figure S3).

• Download figure
• Open in new tab

FIGURE 6

Keyword clusters for the effect of intestinal microbes on obesity research.

3.5.3 Burst detection

CiteSpace was further used to perform burst detection with high frequency and therefore revealed research frontiers and hotspot trends over a period. As shown in Supplementary Table S2, the first 25 keywords were sorted by strengths of burst to discover the research hotspots about the effects of intestinal microbes on obesity. Keywords such as “ecology” (strength 28.33), “human gut microbiota” (strength 27.34), “microbiota” (strength 23.44), “diet induced obesity” (strength 21.12), and “irritable bowel disease” (strength 16) were the strongest keywords leading the research boom from 2013-2018. Keywords such as “obese” (strength 9.3) and “serum” (9.69) were the most recent trending keywords. Supplementary Table S3 shows the top 25 references with the strongest citation bursts, which were recognized as a critical milestone and led the development direction of the field for a while.

4.3.1 Basic knowledge

The most frequently cited references possess pivotal academic position in the field. Either positive or negative conclusions from the documents influence others’ research direction. In our study, the top co-cited references were used to investigate the knowledge base for the effects of intestinal microbes on obesity research. Among the top 10 co-cited references, we found that second-generation sequencing was a vital technology that relies on its high-throughput characteristic, making it easy to sequence the transcriptome or genome of a species (Schuster, 2008). With the development of sequencing technology, a large amount of data is generated. To make more accurate and full use of sequencing data, software and data analysis platforms have also been developed. An open-source software package named DADA2 is used for modeling and correcting Illumina-sequenced amplicon errors. With the help of this software, researchers could accurately reconstruct amplicon-sequenced communities at the highest resolution, which ensured the accuracy of the research to the greatest extent (CallahanMcMurdie et al., 2016). Another utility tool named QIIME 2 could serve not only as a marker-gene analysis tool but also as a multidimensional and powerful data science platform that can be rapidly adapted to analyze diverse microbiome features (BolyenRideout et al., 2019). These tools help drive rapid development in microbiome research. With the help of sequencing, recent research found that the richness of the human gut microbiome correlated with human metabolic markers. Individuals with a low bacterial richness were characterized by more marked overall adiposity, insulin resistance and dyslipidemia and a more pronounced inflammatory phenotype when compared with high bacterial richness individuals (Le ChatelierNielsen et al., 2013). Correspondingly, with higher gut microbiome gene richness and A. muciniphila abundance could exhibit the healthiest metabolic status, particularly in fasting plasma glucose, plasma triglycerides and body fat distribution (DaoEverard et al., 2016). The obesity-associated gut microbial species Bacteroides thetaiotaomicron, a glutamate-fermenting commensal, is linked to changes in circulating metabolites, and the abundance of Bacteroides thetaiotaomicron is markedly decreased in obese individuals and inversely correlated with serum glutamate concentration (LiuHong et al., 2017). Human obesity is a heterogeneous condition in the context of pathogenesis, pathophysiology and therapeutic responsiveness. Studies of alterations in the genome—the microbial gut metagenome—may define subsets of adult individuals with different metabolic risk profiles, which could contribute to resolving some of the heterogeneity associated with adiposity-related phenotypes (Le ChatelierNielsen et al., 2013). All these findings suggest that gut microbiome richness is a key factor in maintaining the homeostasis of human health.

The gut microbiome can rapidly respond to an altered diet, and a dynamic balance can be achieved between intestinal microbes and diet immediately, indicating that not only a long-term diet but also a short-term diet can influence the gut microbiome (DavidMaurice et al., 2014). Weight-loss intervention by bariatric surgery partially reversed obesity-associated microbial and metabolic alterations in obese individuals (LiuHong et al., 2017). This means that external interventions can affect intestinal microbes. Research also proved that transmissible and modifiable interactions between diet and microbiota influence host biology. The transformation correlated with invasion of members of Bacteroidales from Ln into Ob microbiota that prevented development of increased adiposity and body mass in Ob cage mates and transformed their microbiota’s metabolic profile to a leanlike state. Therefore, it may be possible to intervene in obesity by targeting the gut microbiota (RidauraFaith et al., 2013), and there is already evidence proving this speculation. Akkermansia muciniphila is a mucin-degrading bacterium that resides in the mucus layer. Research found that A. muciniphila decreased in obese and type 2 diabetic mice, and A. muciniphila treatment reversed high-fat diet-induced metabolic disorders, including fat-mass gain, metabolic endotoxemia, adipose tissue inflammation, and insulin resistance (EverardBelzer et al., 2013). Pasteurized A. muciniphila could enhance its capacity to reduce fat mass development, insulin resistance and dyslipidemia. Moreover, Amuc_1100, a purified membrane protein from Akkermansia muciniphila, could improve the gut barrier and partly recapitulate the beneficial effects of the bacterium (PlovierEverard et al., 2017). All these findings are of great driving significance, indicating that it is feasible to use microbes to treat obesity, but more research is needed to support this hypothesis.

In addition to the underlying effect of intestinal microbes on obesity, substantial evidence has suggested that intestinal microbes also have an effect on type 2 diabetes, which is also a major public health issue throughout the world. A metagenome-wide association study (MGWAS) was used to identify and validate type-2-diabetes-associated markers and to establish the concept of a metagenomic linkage group, which enabled taxonomic species-level analyses. Type 2 diabetes is accompanied by a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens (QinLi et al., 2012). Conversely, high bacterial richness was related to a reduction in insulin resistance (Le ChatelierNielsen et al., 2013), and A. muciniphila treatment could also reverse insulin resistance (EverardBelzer et al., 2013) (Table 8).

4.3.2 Research hotspots

Keywords with high frequency are usually used to accurately reveal the main research interests and hotspots in the field within a certain period, which help researchers to precisely catch up to the research trends from numerous studies. By analyzing the co-occurrence keywords, “gut microbiota” and “obesity” had the highest frequency and centrality ranking the top two, indicating that the main research interests focused on the relationship between “gut microbiota” and “obesity”. The effects of intestinal microbes on obesity have been supported by several trials, which have all shown that intestinal microbes modulate the metabolism of obesity (EverardBelzer et al., 2013; Le ChatelierNielsen et al., 2013; RidauraFaith et al., 2013). The clustering function was used to show the whole network map. The 8 clusters of keywords presented in this paper illustrate 8 research topics, which to some extent represent 8 significant aspects of the research. Studies in the same cluster might have similar research themes. As shown in Figure 6, the top two largest clusters, “diversity” # 0 and “insulin resistance” # 1, showed that the two topics were still the main themes in the effect of intestinal microbes on obesity research. Simultaneously, a timeline view analysis was conducted to further observe the evolution pace of each cluster and recognize the pivotal research direction through a microperspective. We can clearly observe in Supplementary Figure S3 that the research focus has shifted with time; by 2020, the research on several topics was more balanced. After 2020, the research in the “shot-chain fatty acids” #2 and “activation” #3 directions gradually weakened. The results indicated that gut microbiome research and the treatment of obesity and obesity-related diseases have become the main themes.

Furthermore, burst detection was an analytic tool that could effectively capture the dramatic increases in references or keywords in one research field within a specified period; therefore, it served as an important indicator of research hotspots or research frontiers over time. The evolution of the burst keywords over the last 10 years is shown in Supplementary Table S2. According to the ranking by burstiness strength, we observed that the top 15 keywords started to burst in 2013, and “ecology” remained the longest with an end time in 2018. More importantly, the “obese patient” and “serum” burst separately in 2019 and 2020 and continue to burst until now, which indicated that the two topics have received continuous attention in recent years and might be the main trends of research on the effect of intestinal microbes on obesity. Notably, there was a sudden and rapid growth in the number of articles in the field, which might be related to the term “serum”, which was only a new burst in that year.

Bariatric surgery is considered the only effective and sustainable weight loss method for obese patients. There is a 50–70% decrease in body weight and fat mass after surgical procedures such as Roux-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) (PaganelliLuyer et al., 2019). Nevertheless, obese patients undergoing bariatric surgery may experience overgrowth of small intestinal bacteria (SabateCoupaye et al., 2017), a condition that snags with weight loss and increases the risk of micronutrient deficiency that appears to be harmful for the configuration and composition of intestinal microbiota (HibberdWu et al., 2017; Mach and Clark, 2017). To maintain the effect of surgery and avoid weight rebound, it is important for obese patients to correct the microbial balance and improve microbiota-host interactions with specific interventions (Aron-WisnewskyPrifti et al., 2019). Research has also shown that the elevated pH resulting from RYGB could ensure the survival of probiotic bacteria, making it possible for surgical patients to receive probiotic therapy (80). Probiotics are a kind of active microorganism beneficial to the host that colonizes the human intestinal tract and reproductive system, and they can improve the host microecological balance and play a beneficial role. Bariatric surgery is often followed by an increase in Streptococcaceae and a decline in Bifidobacteriaceae (PaganelliLuyer et al., 2019). Proper supplementation with probiotics can compensate for the intestinal microbial imbalance caused by surgery. Moreover, recent research showed that probiotic intervention could increase the levels of peptide YY and GLP-1 in mice (TianLi et al., 2016), reduce the level of intestinal inflammation (TsaiLin et al., 2019), and induce the production of anti-inflammatory cytokines (FolignéParayre et al., 2016). Meanwhile, intestinal peptide signals activate the gut-brain axis, which, in turn, exerts endocrine effects on other organ systems, especially the brain, regulating appetite, metabolism, and other dietary behaviors(Bliss and Whiteside, 2018; Hussain and Bloom, 2013; NeyrinckVan Hée et al., 2012; RastelliVan Hul et al., 2020). Consequently, weight loss and reduced insulin resistance occur. However, due to the heterogeneity of experimental techniques, methods and objects, the effectiveness and safety of microbial product intervention in improving obesity against intestinal microbiota need to be further verified, and the mechanism is not clear. Few studies have focused on the development of new functional microbiological products, and most of them have been carried out in mice. Before microbial products are reasonably and effectively treated for obesity, a large number of studies are needed, especially randomized controlled clinical trials.

Serum samples are a less invasive biomatrix that reflects the dynamic changes in the metabolome of the whole organism (DunnBroadhurst et al., 2011). The serum metabolome has emerged as a technique that focuses on defining the functional status of host-microbial relationships in biological specimens, which can reflect the dynamic changes in metabolites and explore disease-related metabolites or dysregulated metabolic pathways (metabolome analysis for investigating host-gut microbiota interactions). A top 10 co-cited reference showed the gut microbiome and serum metabolome alterations in obesity that patients after bariatric surgery not only appeared partially reversed obesity-associated microbial but also accompanied by metabolic alterations, including the decreased abundance of B. thetaiotaomicron and the elevated serum glutamate concentration, suggesting that it may be possible to intervene in obesity by targeting the gut microbiota (LiuHong et al., 2017). There are complex interactions between the host and intestinal microbes in carbohydrate, amino acid, lipid and nucleic acid metabolism. Intestinal microbes can use their respective metabolites to maintain intestinal viability while affecting the development, homeostasis and function of the host immune system through nutrition- and metabolite-dependent mechanisms (Brestoff and Artis, 2013). Small molecules, such as vitamins, fatty acids, amino acids, and bile acids, regulate host-intestinal metabolic homeostasis by binding to specific host membranes or nuclear receptors (HustedTrauelsen et al., 2017; PutignaniDel Chierico et al., 2016). The references with the highest citation bursts are unique contributions to the field of study. We found that articles related to bile acids have become the most cited articles in recent years (KohDe Vadder et al., 2016; WangLiao et al., 2019). Bile acids directly and rapidly affect the metabolism of bacteria, including membrane damage and disruption of amino acid, nucleotide and carbohydrate metabolism, and short-term exposure to bile acids significantly affects host metabolism by altering the bacterial community structure (TianGui et al., 2020). Another study showed that the gut microbiota also produced many other metabolites with important functions, such as short-chain fatty acids (SCFAs) and bile acids (KrishnanDing et al., 2018). Short-chain fatty acids can directly activate G-coupled receptors, inhibit histone deacetylases, and serve as energy substrates (KohDe Vadder et al., 2016). They thus affect various physiological processes and may contribute to health and disease. According to the above analysis, although notable advances in the effects of intestinal microbes on obesity have been made, our understanding of the interrelationships between them remains descriptive, and we still have numerous gaps to fill.